Amalgamated Bank’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
ACM
CAM
SI
OCA
RCM
VCM
B
Amalgamated Bank's BIOA Position: Q1 2026 in Review
Amalgamated Bank sold out of BioAge Labs (BIOA) in Q1 2026, closing a stake of 745 shares — an estimated $10K sold.
Amalgamated Bank first reported a position in BIOA in Q4 2024 and held it in 5 quarters. The position peaked at $10K in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.
- Amalgamated Bank reported no remaining BioAge Labs position as of Q1 2026 after selling out during the quarter.
- Amalgamated Bank sold 745 BioAge Labs shares in Q1 2026, an estimated $10K.
- Amalgamated Bank first reported a position in BioAge Labs in Q4 2024 and held it in 5 quarters.
- Amalgamated Bank's BioAge Labs position peaked at $10K in Q4 2025.
- 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.
Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.